PARS PLANA VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR AND SUBRETINAL BEVACIZUMAB INJECTION WITH INTRAVITREAL SF-6 GAS FOR TREATMENT OUTCOMES FOR SUBMACULAR HEMORRHAGE SECONDARY TO AGE RELATED MACULAR DEGENERATION
2 October 2024
•
0 Comment